Cite Filings / CRSP / 0001950047-26-000625
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

CRISPR Therapeutics AG · Filed 2026-01-22 · Acc 0001950047-26-000625

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-01-27 4 Chief Medical Officer bought 1,508 shares at $32.96 ($49,704)
  • 2026-01-26 4 Chief Financial Officer sold 34,972 shares at $60.19 ($2,104,965)
  • 2026-01-22 144 Sale of Securities
  • 2026-01-22 144 Sale of Securities
  • 2026-01-22 4 Chief Executive Officer sold 90,000 shares at an average $57.40 ($5,166,298)
  • 2026-01-20 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…